Project Grant HT94252510860
Award Date 10/1/25
Completion Date 9/30/27
Dollars Obligated $300K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- This Project Grant award for $300,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research into novel mechanisms that prevent systemic lupus erythematosus (SLE). The award was made to the New York Society for the Relief of Ruptured & Crippled, Maintaining the Hospital for Special Surgery, a prominent non-profit orthopedic and rheumatology hospital in New York City. The research project aims to advance the...
- This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
- The University of Pittsburgh was awarded a $494,458 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research to regulate profibrotic SPP1-expressing macrophages by TFEB in SSc. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative medical...
- The Department of the Army Medical Command awarded Monash University a $1,498,168 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Targeted Regulatory T Cells to Treat SLE from September 1, 2022 through August 31, 2025. Under this award, Monash University will conduct research to investigate medical solutions for systemic lupus erythematosus (SLE) by developing targeted regulatory T cells as an innovative treatment approach. The...
- The federal Project Grant award of $726,989 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Pittsburgh to investigate immunotherapeutic targeting of the SLC39A9 protein in CDKN2A-low melanoma. The award, with a performance period from September 2025 to September 2028, aims to transform healthcare for military service members and the broader public by advancing innovative biomedical research into cancer...
- This $300,000 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel CAR T-cell therapy for selectively depleting autoimmune B cells in lupus. The award was granted to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a prominent private research university and academic medical center located in Philadelphia. The...
- This $434,722 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program is funding a collaborative effort by the University of Pittsburgh to molecularly characterize and stratify pediatric scleroderma patients. The award will support a multiomic research approach to advance the understanding and treatment of this rare autoimmune disease that affects children. The 4-year project, with a performance period from Aug 2025 to Aug...
- The University of Pittsburgh has been awarded a $2,671,990 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "A Collaborative Multiomics Approach to Pediatric Scleroderma (CMAPS) to Molecularly Characterize and Stratify Patients," will support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research will...
- The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
- This Project Grant award, worth $647,861.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The funding will support a 3-year research project evaluating the interplay between B-cells and T-cells within the tumor microenvironment of melanoma, and the impact on immune checkpoint blockade therapies. The University of Pittsburgh, a major recipient of federal biomedical research grants, will...